Professor Valerie Schini-Kerth

Professor Valerie Schini-Kerth

INSERM, University of Strasbourg, CRBS, Strasbourg (France)

Member of:

Valérie Schini-Kerth received her PhD in 1988 at the University Louis Pasteur of Strasbourg, France. She is Professor of Pharmacology at the Faculty of Pharmacy of Strasbourg University since 2000. Since January 2024, she is the director of the Translational Cardiovascular Medicine research department. Her major interest is focusing on the pivotal role of the endothelium in the control of vascular homeostasis in health and disease. In particular, she is studying the mechanisms contributing to the induction of endothelial dysfunction related to ageing and major cardiovascular risk factors including hypertension and diabetes. Her recent interest is focusing on the role of premature endothelial senescence in the initiation of endothelial dysfunction and its pharmacological inhibition by drugs and natural products including berry-derived products. She is currently the Chair of the Natural Products Section of the International Union of Basic and Clinical Pharmacology (IUPHAR).

Presentations Articles

Sodium-glucose co-transporter 1 and 2 expression in the mammary artery of patients with bypass surgery: role of the pro-inflammatory response and contribution to oxidative stress

Event: ESC Congress 2021 - The Digital Experience

Topic: Drugs, Drug Targets

Session: Basic science e-posters

Access

Cardiac diastolic dysfunction in angiotensin II-treated hypertensive rats is associated with endothelial upregulation of SGLT1/2 in the macro and microcirculation: Protective effect of empagliflozin

Event: Heart Failure 2021

Topic: Heart Failure

Session: ePoster session

Access

Empagliflozin treatment does not affect the hypertensive response to Ang II administration to rats but decreases oxidative stress in the arterial wall, and endothelial and cardiac dysfunction

Event: ESC Congress 2020

Topic: Hypertension, Pulmonary Hypertension

Session: Pulmonary Hypertension: Targets for Therapies

Access

Coated EPA:DHA 6:1 nanoparticles cause greater endothelium-dependent relaxations of coronary artery rings than the native form: role of NO, endothelium-dependent hyperpolarization and prostanoids

Event: ESC Congress 2018

Topic: Vascular Tone, Permeability, Microcirculation

Session: Vascular pathophysiology

Access

Oral intake of EPA:DHA 6:1 improves ageing-related blunted endothelium-dependent relaxations and increased contractile responses in the mesenteric artery: role of oxidative stress and cyclooxygenases

Event: ESC Congress 2017

Topic: Endothelial function

Session: Vascular biology and the microcirculation

Access

EPA:DHA 6:1 is a superior omega 3 formulation preventing platelet-induced 5-HT-mediated contractile responses in porcine coronary artery and human mammary artery rings: role of endothelial NO

Event: ESC Congress 2016

Topic: Endothelial function

Session: Endothelium, the microcirculation and vascular biology

Access

ESC 365 is supported by

Explore sponsored resources

Professor Valerie Schini-Kerth

Biography

Contributor content

Sodium-glucose co-transporter 1 and 2 expression in the mammary artery of patients with bypass surgery: role of the pro-inflammatory response and contribution to oxidative stress

Cardiac diastolic dysfunction in angiotensin II-treated hypertensive rats is associated with endothelial upregulation of SGLT1/2 in the macro and microcirculation: Protective effect of empagliflozin

Empagliflozin treatment does not affect the hypertensive response to Ang II administration to rats but decreases oxidative stress in the arterial wall, and endothelial and cardiac dysfunction

Coated EPA:DHA 6:1 nanoparticles cause greater endothelium-dependent relaxations of coronary artery rings than the native form: role of NO, endothelium-dependent hyperpolarization and prostanoids

Oral intake of EPA:DHA 6:1 improves ageing-related blunted endothelium-dependent relaxations and increased contractile responses in the mesenteric artery: role of oxidative stress and cyclooxygenases

EPA:DHA 6:1 is a superior omega 3 formulation preventing platelet-induced 5-HT-mediated contractile responses in porcine coronary artery and human mammary artery rings: role of endothelial NO

ESC 365 is supported by

Professor Valerie Schini-Kerth Follow

Biography

Contributor content

Sodium-glucose co-transporter 1 and 2 expression in the mammary artery of patients with bypass surgery: role of the pro-inflammatory response and contribution to oxidative stress

Cardiac diastolic dysfunction in angiotensin II-treated hypertensive rats is associated with endothelial upregulation of SGLT1/2 in the macro and microcirculation: Protective effect of empagliflozin

Empagliflozin treatment does not affect the hypertensive response to Ang II administration to rats but decreases oxidative stress in the arterial wall, and endothelial and cardiac dysfunction

Coated EPA:DHA 6:1 nanoparticles cause greater endothelium-dependent relaxations of coronary artery rings than the native form: role of NO, endothelium-dependent hyperpolarization and prostanoids

Oral intake of EPA:DHA 6:1 improves ageing-related blunted endothelium-dependent relaxations and increased contractile responses in the mesenteric artery: role of oxidative stress and cyclooxygenases

EPA:DHA 6:1 is a superior omega 3 formulation preventing platelet-induced 5-HT-mediated contractile responses in porcine coronary artery and human mammary artery rings: role of endothelial NO

ESC 365 is supported by

Professor Valerie Schini-Kerth